M. Katschinski et al., INTESTINAL PHASE OF HUMAN ANTRO-PYLORO-DUODENAL MOTILITY - CHOLINERGIC AND CCK-MEDIATED REGULATION, European journal of clinical investigation, 26(7), 1996, pp. 574-583
Citations number
42
Categorie Soggetti
Medicine, Research & Experimental","Medicine, General & Internal
In this study the muscarinic receptor antagonist atropine and the chol
ecystokinin (CCK)-A receptor antagonist loxiglumide were used to inves
tigate the relative importance of cholinergic and CCK-mediated regulat
ion of intestinal phase antro-pyloro-duodenal motility. Plasma levels
of gastrointestinal hormones [pancreatic polypeptide (PP), gastrin, CC
K] were concomitantly determined to estimate biological potency of the
doses of the receptor antagonists. In eight healthy male volunteers,
a 30-min basal interdigestive period was followed by duodenal perfusio
n of a mixed liquid meal for 150 min at 2.6 kcal min(-1) against a bac
kground of saline or atropine (5 mu g kg(-1) h(-1)) or loxiglumide (10
mg kg(-1) h(-1)). Antro-pyloro-duodenal motility was continuously mon
itored with a sleeve straddling the pylorus. Against a background of s
aline, duodenal nutrients persistently stimulated isolated pyloric pre
ssure waves. After 60 min, the initially low antral and duodenal contr
action rates increased. In the fed state, atropine reduced total numbe
r of antral contractions and integrated motility index by 73% (P < 0.0
1) and 76% (P < 0.005), total number of pyloric contractions and integ
rated motility index by 43% and 50% (P < 0.05) with inhibition increas
ing over time. It did not alter duodenal contraction frequency but dim
inished duodenal motility index by 39% (P < 0.05) owing to a reduction
in amplitude and duration of contractions. Loxiglumide decreased tota
l numbers of antral, pyloric and duodenal contractions by 44% (P < 0.0
5), 74% (P < 0.005) and 41% (P < 0.005) respectively. It reduced cumul
ative antral, pyloric and duodenal motility indexes by 60% (P < 0.01),
80% (P < 0.01) and 61% (P < 0.05) respectively. Atropine fully abolis
hed PP release to duodenal nutrients whereas loxiglumide reduced it by
60% (P < 0.05). Both atropine and loxiglumide enhanced gastrin releas
e whereas only loxiglumide markedly stimulated CCK release. We conclud
e that both cholinergic input and endogenous CCK are major stimulatory
regulators of antro-pyloroduodenal motility in the intestinal phase.
There appears to be a regional heterogeneity of cholinergic and CCK co
ntrol. Cholinergic input predominates in the antrum. Both systems are
equipotent at the pylorus. CCK predominates in the duodenum. We sugges
t that CCK primarily interacts with receptors on cholinergic neurons i
n the antropyloric region and primarily affects smooth muscle receptor
s in the duodenum.